How much is GC Therapeutics worth in 2026?

GC Therapeutics has a current valuation of $135.0M based on their Later Stage VC round and secondary market data.

How much funding has GC Therapeutics raised?

GC Therapeutics has raised $74.7M in total funding across 1 funding rounds.

GC Therapeutics

Website

GC Therapeutics valuation and funding history | Last updated: September 19, 2024 | 1 funding rounds

Current Valuation

$135.0M

As of September 19, 2024

Total Funding Raised

$74.7M

Across 1 round

Last Round

Later Stage VC

$65.0M

Last Funding

Sep 2024

Funding date

Capital Efficiency

1.81x

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
N/A	Unknown	Undisclosed	N/A	-

Valuation Analysis

Current Valuation Metrics

GC Therapeutics is currently valued at $135.0M as of September 19, 2024. The company has raised a total of $74.7M in funding across 1 funding round.

Capital Efficiency

With a capital efficiency ratio of 1.81x, GC Therapeutics has achieved a valuation that is 1.81 times the total capital raised.

Track GC Therapeutics Valuation Updates

Get notified when GC Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for GC Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock GC Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is GC Therapeutics Worth in 2026?

GC Therapeutics is a leading private company in the technology sector. Track GC Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How GC Therapeutics Valuation is Determined

Private company valuations like GC Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.